Open AccessRandomized trial of pegylated interferon α-2b monotherapy in haemodialysis patients with chronic hepatitis C
Author(s) -
Mark W. Russo,
Reem Ghalib,
Samuel H. Sigal,
Viren Joshi
Publication year - 2005
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfi231
Subject(s) - medicine , pegylated interferon , chronic hepatitis , hemodialysis , hepatitis c , randomized controlled trial , interferon , gastroenterology , ribavirin , immunology , virus
Chronic hepatitis C infection is prevalent among haemodialysis patients. The goal of our study was to determine the efficacy and safety of pegylated interferon alpha-2b in haemodialysis patients with chronic hepatitis C.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom